Who Owns Corvus Pharmaceuticals Stock?
NASDAQ: CRVSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 83.07%
- Held by insiders
- 3.50%
- Institutional holders
- 245
- Institutions 83.1%
- Insiders 3.5%
- Public and other 13.4%
Who owns Corvus Pharmaceuticals stock?
Institutional investors own about 83.1% of Corvus Pharmaceuticals's shares, spread across 245 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 3.50% of CRVS.
The largest institutional holders are Orbimed Advisors LLC. (8.49%), Blackrock Inc. (8.42%) and State Street Corporation (3.95%). Together, the top 10 institutions control 45.9% of shares outstanding. In their latest filings, 3 of the top 10 institutions increased their CRVS positions and 4 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of CRVS
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Orbimed Advisors LLC. | 7.17M | 8.49% | 0.0% |
| Blackrock Inc. | 7.10M | 8.42% | -0.5% |
| State Street Corporation | 3.33M | 3.95% | -25.5% |
| Vanguard Capital Management LLC | 3.32M | 3.93% | +0.8% |
| Hood River Capital Management LLC | 3.31M | 3.93% | +110.8% |
| Adams Street Partners, LLC | 3.28M | 3.88% | 0.0% |
| Price (T.Rowe) Associates Inc | 3.06M | 3.62% | -19.3% |
| Wellington Management Group, LLP | 2.85M | 3.38% | +4.4% |
| Vivo Capital, LLC | 2.81M | 3.33% | 0.0% |
| Perceptive Advisors Llc | 2.51M | 2.98% | -5.9% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of CRVS
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.37M | 2.81% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 1.81M | 2.15% |
| iShares Trust-iShares Russell 2000 ETF | 1.66M | 1.97% |
| Manager Directed Portfolios-Hood River Small-Cap Growth Fund | 1.59M | 1.88% |
| T. Rowe Price New Horizons Fund, Inc. | 963.96K | 1.14% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 844.72K | 1.00% |
| T. ROWE PRICE QUANTITATIVE Mgmt Fd.S, INC.-T. Rowe Price Integrated U. | 801.90K | 0.95% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 742.66K | 0.88% |
| T. Rowe Price Health Sciences Fund, Inc. | 616.39K | 0.73% |
| iShares Trust-iShares Russell 2000 Growth ETF | 597.33K | 0.71% |
Frequently asked questions
Who is the largest shareholder of Corvus Pharmaceuticals?
Orbimed Advisors LLC. is the largest institutional shareholder of CRVS, owning 8.49% of shares outstanding (7.17M shares) as of its latest 13F filing.
What percentage of Corvus Pharmaceuticals is owned by institutions?
Institutions own about 83.1% of CRVS shares and 86.1% of the public float.
How much of Corvus Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 3.50% of CRVS shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.